The MedicX Fund Limited Block listing application (8070N)
August 11 2017 - 6:42AM
UK Regulatory
TIDMMXF
RNS Number : 8070N
The MedicX Fund Limited
11 August 2017
For immediate release
11 August 2017
MedicX Fund Limited
("MedicX Fund", "the Fund" or "the Company")
Block listing application
MedicX Fund Limited (LSE: MXF), the specialist primary care
infrastructure investor in modern purpose-built primary healthcare
properties in the United Kingdom and Republic of Ireland, has made
an application to the UK Listing Authority for a block listing, for
general business purposes, of 14,771,668 ordinary shares of no par
value to be admitted to The Official List of the UK Listing
Authority and to trading on The London Stock Exchange's main market
for listed securities.
Shares issued under the block listing will be used to satisfy
continuing market demand and the proceeds of share issuance under
the block listing will be used for investment in accordance with
the Company's investment policy.
The block listing is expected to become effective at 8.00 a.m.
on 14 August 2017.
- End -
For further information please contact:
MedicX Fund +44 (0) 1481 723 450
David Staples, Chairman
Octopus Healthcare Group +44 (0) 20 3142 4820
Mike Adams, Chief Executive Officer
Canaccord Genuity +44 (0) 20 7523 8000
Andrew Zychowski/Helen Goldsmith
Buchanan +44 (0) 20 7466 5000
Charles Ryland/Vicky Hayns
Information on MedicX Fund Limited
MedicX Fund Limited ("MXF", "MedicX Fund", the "Fund" or the
"Company", or together with its subsidiaries, the "Group") is the
specialist primary care infrastructure investor in modern,
purpose-built primary healthcare properties in the United Kingdom
and Ireland, listed on the London Stock Exchange, with a portfolio
comprising 157 properties.
The Investment Adviser to the Company is Octopus Healthcare
Adviser Ltd, which is part of the Octopus Healthcare group. Octopus
Healthcare invests in and develops properties as well as creating
partnerships to deliver innovative healthcare buildings to improve
the health, wealth and wellbeing of the UK. It currently manages
over GBP1 billion of healthcare investments across a number of
platforms, with a focus on five core areas: GP surgeries, care
homes, special education schools, retirement housing and private
hospitals. Octopus Healthcare is part of the Octopus group, a
fast-growing UK fund management business with leading positions in
several specialist sectors including healthcare property, energy,
property finance and smaller company investing. Octopus manages
GBP6 billion of funds for more than 50,000 retail and institutional
investors.
Octopus Healthcare Adviser Ltd is authorised and regulated by
the Financial Conduct Authority.
The Company's website address is www.medicxfund.com. Neither the
contents of the Company's website nor the contents of any website
accessible from hyperlinks on the Company's website (or any other
website), nor the contents of any website accessible from
hyperlinks within this announcement, are incorporated into, or
forms part of, this announcement.
The Company's Legal Entity Identifier is
2138008POF35FTNFCB25.
This information is provided by RNS
The company news service from the London Stock Exchange
END
ALSLLFSLTIILLID
(END) Dow Jones Newswires
August 11, 2017 07:42 ET (11:42 GMT)
Medicx (LSE:MXF)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medicx (LSE:MXF)
Historical Stock Chart
From Apr 2023 to Apr 2024